News

Filter

176 to 185 of 97252 results

Zydus launches world’s first biosimilar of Humira

Zydus launches world’s first biosimilar of Humira

09-12-2014

A biosimilar of AbbVie’s blockbuster drug Humira (adalimumab) has been launched in India by generic…

AbbVieAnti-Arthritics/RheumaticsBiosimilarsHumiraIndiaMarkets & MarketingZydus Cadila

ASH 2014: Gilead announces good response rates for Zydelig in non-Hodgkin lymphoma

ASH 2014: Gilead announces good response rates for Zydelig in non-Hodgkin lymphoma

09-12-2014

US biotech major Gilead Sciences has announced long-term follow-up results from the registration studies…

Gilead SciencesOncologyPharmaceuticalResearchUSAZydelig

Bayer collaborates with DNDi on novel, oral human river blindness treatment

09-12-2014

German pharma major Bayer and the Drugs for Neglected Diseases initiative (DNDi) have signed an agreement…

Astellas PharmaBayeremodepsidePharmaceuticalResearchTropical diseases

Calithera gains exclusive, global license to Mars Symbioscience's arginase inhibitors

09-12-2014

Calithera Biosciences has signed an exclusive global license agreement with Mars Symbioscience, a division…

BiotechnologyCalithera BiosciencesGlobalLicensingMars SymbioscienceOncology

Supernus notified of Par Pharma ANDA filing for Trokendi XR generic

09-12-2014

US drugmaker Supernus Pharmaceuticals says that it has received a Paragraph IV Notice Letter from privately-held…

GenericsNeurologicalPar PharmaceuticalsPatentsRegulationSupernus PharmaceuticalsTrokendi XRUSA

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

Effective malaria control dramatically reduces deaths, but challenges remain, report warns

09-12-2014

Effective malaria control has dramatically reduced the number of people dying from the disease since…

Anti-viralsAntibiotics and Infectious diseasesPharmaceuticalResearchRest of the World

AstraZeneca’s Moventig gains EU approval for OIC

09-12-2014

The European Commission has granted marketing authorization for Anglo-Swedish pharma major AstraZeneca’s…

AstraZenecaEuropeGastro-intestinalsMoventigNektar TherapeuticsPharmaceuticalRegulation

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

India’s regulator approves Sun Pharma’s acquisition of Ranbaxy, but with conditions

09-12-2014

The Indian Competition Commission has granted domestic generics company Sun Pharmaceutical Industries…

IndiaMergers & AcquisitionsPharmaceuticalRanbaxySun Pharmaceutical

176 to 185 of 97252 results

Back to top